You are here :
Number of results: 5 found:


Among patients with NYHA class II or III heart failure, a wide QRS complex, and left ventricular systolic dysfunction, the addition of CRT to an ICD reduced rates of death and hospitalization for heart failure.
TRUST is the first and largest clinical trial to demonstrate the safety and efficacy of daily remote monitoring with BIOTRONIK Home Monitoring. This multi-center, prospective, randomized trial enrolled 1,450 pati ...
The COMPAS trial is the first & only large-scale pacemaker patient study to demonstrate that daily automatic remote monitoring with BIOTRONIK Home Monitoring® is safe and effective in the long-term and significan ...
The EchoCRT landmark trial evaluates the effects of Cardiac Resynchronization Therapy (CRT) on mortality and morbidity in patients with advanced heart failure.
BIOTRONIK’s AlCath® Gold Ablation Catheter outperforms platinum-iridium tips for typical atrial flutter ablation.

Cardiostim 2012

Congress Contents

Education

Abstracts

Registration

Exhibits

Practical Information